Effect of oral mexiletine on the cough response to capsaicin and tartaric acid.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 10639529.
- Also identified by PMC identifier 1745676.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The effect of the orally active local anaesthetic mexiletine on the cough response to two different tussive agents, a C-fibre ending stimulator capsaicin and a chemostimulant tartaric acid, was examined in normal subjects. The cough threshold, defined as the lowest concentration of capsaicin (C(5)-CP) or tartaric acid (C(5)-TA) causing five or more coughs, and histamine induced bronchoconstriction were measured three hours after a single oral dose of 300 mg mexiletine or placebo in 14 normal subjects. Mexiletene in a mean (SE) serum concentration of 0.99 (0. 04) microg/ml significantly increased C(5)-TA from a geometric mean (SE) of 32.0 (1.27) mg/ml with placebo to 49.9 (1.34) mg/ml, but C(5)-CP did not differ significantly between treatment with mexiletine (12.2 (1.33) microM) and placebo (14.9 (1.23) microM). These results suggest that the cough response to capsaicin and tartaric acid may be mediated in part via different neural pathways.
Medical subject headings
- Anti-Arrhythmia Agents
- Antitussive Agents
- Capsaicin
- Cough
- Mexiletine
- Tartrates